2010 Hemostasis Gordon Research Conference and/or Gordon Research Seminar

2010 止血戈登研究会议和/或戈登研究研讨会

• 批准号: 7911112
• 负责人: Nigel Mackman
• 金额: $ 1万
• 依托单位: GORDON RESEARCH CONFERENCES
• 依托单位国家: 美国
• 财政年份: 2010
• 资助国家: 美国
• 起止时间: 2010-04-01 至 2011-03-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7911112
• 关键词: Anticoagulants; Area; Biology; Blood Clot; Blood Platelets; Blood coagulation; Cause of Death; Coagulation Process; Consultations; Diagnosis; Disabled Persons; Discipline; Disease; Fibrin; Goals; Hemostatic function; Hour; Individual; International; Location; Maine; Minority Groups; New Hampshire; Participant; Pathway interactions; Postdoctoral Fellow; Research; Science; Senior Scientist; Thrombosis; Time; Underrepresented Minority; Woman; Writing; college; design; graduate student; improved; meetings; planetary Atmosphere; posters; programs; public health relevance; symposium

DESCRIPTION (provided by applicant): This application seeks partial support for the bi-annual Gordon Conference (GRC) on Hemostasis and/or its preceding Gordon Research Seminar (GRS). The broad and long term goal of the conference is to increase our understanding of the fundamental mechanisms that regulate formation of a platelet-fibrin clot. The last two highly successful Hemostasis GRCs were held at Colby College, Maine in 2006 and Waterville Valley, New Hampshire in 2008. The next conference will be held on July 25th - July 30th 2010 at Waterville Valley Conference Center, Waterville Valley, New Hampshire. The 2008 found this venue to be a comfortable and inviting location. Always oversubscribed, well-attended, and highly evaluated by its participants, the GRC on Hemostasis for 2010 will be comprised of nine 3 hour sessions that will be held in the allotted morning and evening time slots. Poster presentations will be held before dinner on four of the five days. These are always very well-attended, and provide a dedicated, informal forum for interaction between junior and more senior scientists in the field. A Hot Topics Session, quickly becoming a tradition at our GRC, is planned for Wednesday night. The specific aims of this meeting will be to convene 39 Speakers and Discussion Leaders that represent critical areas of hemostasis research with a total of approx. 150 participants for a five day conference in a relatively isolated setting. The Speakers and Discussion Leaders have been carefully chosen by the Chair and Vice-Chair after extensive, careful consideration and consultation with former Chairs of the 2004, 2006, and 2008 Hemostasis GRC. Of these, we already have written acceptances from all participants. We have also made a concerted effort to achieve appropriate representation of women, racial and ethnic minorities, persons with disabilities, and other individuals from groups that have traditionally been underrepresented in science as Speakers and Discussion Leaders. Our current list of invited speakers and discussion leaders already includes 8 women, and we expect to increase the representation of women among our speakers, as well as including underrepresented minorities, in the Hot Topics session. The program is designed to provide an invigorating meeting covering a range of timely disciplines in the fields of thrombosis and hemostasis. A two day Gordon Research Seminar will precede the meeting and will allow post-docs and graduate students to interact in a more relaxed atmosphere. The significance of this application is that the Hemostasis GRC is widely considered to be the premiere small meeting on the topics of blood coagulation, platelet biology, and anticoagulant pathways, enjoying both national and international reputation. First organized by hemostasis pioneers Earl W. Davie and Oscar Ratnoff in 1973. The healthy relatedness of this application is that thrombosis is the leading cause of death in the US and there is an urgent need for improving diagnosis and treatment of this devastating disease. PUBLIC HEALTH RELEVANCE: Thrombosis is the leading cause of death in the US and there is an urgent need for improving diagnosis and treatment of this devastating disease. The goal of the conference is to increase our understanding of the fundamental mechanisms that regulate formation of a blood clot. The Hemostasis GRC is widely considered to be the premiere small meeting, on the topics of blood coagulation, platelet biology, and anticoagulant pathways, enjoying both national and international reputation.

描述（由申请人提供）： 本申请寻求对一年两次的戈登止血会议（GRC）和/或之前的戈登研究研讨会（GRS）的部分支持。会议的广泛和长期目标是增加我们对血小板纤维蛋白凝块形成的基本机制的理解。最近两次非常成功的止血GRC分别于2006年在缅因州的科尔比学院和2008年在新罕布什尔州的沃特维尔谷举行。下次会议将于2010年7月25日至7月30日在新罕布什尔州沃特维尔谷的沃特维尔谷会议中心举行。2008年发现这个地方是一个舒适和诱人的位置。2010年的GRC止血会议总是超额认购，与会者踊跃参加，并得到与会者的高度评价，该会议将由9个3小时的会议组成，将在分配的上午和晚上时间段举行。海报展示将在五天中的四天晚餐前举行。这些会议的参加人数总是很高，为该领域的初级和高级科学家之间的互动提供了一个专门的非正式论坛。一个热门话题会议，迅速成为一个传统，在我们的GRC，计划在星期三晚上。本次会议的具体目标是召集代表止血研究关键领域的39位发言人和讨论负责人，共计约100人。150名与会者在一个相对孤立的环境中参加了为期五天的会议。主席和副主席经过广泛、仔细的考虑并与2004年、2006年和2008年止血GRC前主席协商后，精心挑选了发言人和讨论领导人。其中，我们已经收到了所有参与者的书面接受。我们还作出了协调一致的努力，以实现妇女，种族和少数民族，残疾人，以及其他个人的群体，传统上在科学作为发言人和讨论领袖代表性不足的适当代表性。我们目前的受邀演讲者和讨论领导者名单中已经包括8名女性，我们希望在热门话题会议中增加女性在我们演讲者中的代表性，并包括代表性不足的少数民族。该计划旨在提供一个令人振奋的会议，涵盖血栓形成和止血领域的一系列及时学科。为期两天的戈登研究研讨会将在会议之前，将允许博士后和研究生在一个更轻松的气氛中互动。这一应用的意义在于，止血GRC被广泛认为是关于血液凝固，血小板生物学和抗凝剂途径主题的首次小型会议，享有国内和国际声誉。首先由止血先驱Earl W. 1973年，戴维和奥斯卡·拉特诺夫。该应用的健康相关性在于血栓形成是美国的主要死亡原因，并且迫切需要改善这种毁灭性疾病的诊断和治疗。公共卫生关系：血栓形成是美国死亡的主要原因，迫切需要改善这种毁灭性疾病的诊断和治疗。会议的目标是增加我们对调节血栓形成的基本机制的理解。止血GRC被广泛认为是关于血液凝固，血小板生物学和抗凝剂途径的首次小型会议，享有国内和国际声誉。